Research > Clinical Medicine

Obesity, DIabetes and Metabolism Research Group (ODIM)

The main lines of research of the Group are organized around 4 main branches:

  • Morbid obesity and its comorbidities, with great interest in the development of personalized medicine, based on:
    • The genetic propensity to develop comorbidities such as non-alcoholic fatty liver, apnea syndrom or type 2 diabetes mellitus.
    • The ability to predict comorbidity resolution and weight loss after bariatric surgery.
  • The study of cellular and molecular signaling mechanisms involved in the cellular response to insulin, initially focused on the characterization of PKRN1 phosphokinase.
  • Deepen the study of cardiovascular disease in the "other" diabetes: diabetes mellitus type 1, diabetes type LADA, and monogenic diabetes.
  • Confirmation that the lung is the target organ of late complications of type 2 diabetes mellitus.

Contact information

Albert Lecube Torelló

Albert Lecube Torelló